[RUN_AMAF] provider=mistral | model=mistral-small-latest
DEBUG: Initializing agent TabuSynth with provider=mistral, model=mistral-small-latest
DEBUG: Initializing agent Contextron with provider=mistral, model=mistral-small-latest
DEBUG: Initializing agent Visura with provider=mistral, model=mistral-small-latest
DEBUG: Initializing agent SummaCraft with provider=mistral, model=mistral-small-latest
DEBUG: Initializing agent TrendAnalyser with provider=mistral, model=mistral-small-latest
DEBUG: Initializing agent MCP with provider=mistral, model=mistral-small-latest
Attempt 1/5 for examples/finqa/HOLX_2007_page_129.pdf-1.json
DEBUG: _chat called with provider=mistral, model=mistral-small-latest
DEBUG: Using Mistral client.chat.complete() with model=mistral-small-latest
DEBUG: Mistral API call successful, response type: <class 'mistralai.models.chatcompletionresponse.ChatCompletionResponse'>
DEBUG: _chat called with provider=mistral, model=mistral-small-latest
DEBUG: Using Mistral client.chat.complete() with model=mistral-small-latest
DEBUG: Mistral API call successful, response type: <class 'mistralai.models.chatcompletionresponse.ChatCompletionResponse'>
DEBUG: _chat called with provider=mistral, model=mistral-small-latest
DEBUG: Using Mistral client.chat.complete() with model=mistral-small-latest
DEBUG: Mistral API call successful, response type: <class 'mistralai.models.chatcompletionresponse.ChatCompletionResponse'>
âœ… Success on attempt 1

=== FINAL SUMMARY ===

```json
{
  "Question": "what is the fair value of hologic common stock used to acquire suros?",
  "Calculation": "The fair value of Hologic common stock used to acquire Suro is directly provided in the table as the 'Estimated Purchase Price,' which is $267100. No further calculation is needed as the value is explicitly stated.",
  "Answer": "$267100",
  "Source": "table"
}
```

Answer Echoes:
- The fair value of Hologic common stock used to acquire Suro is directly provided as the "Estimated Purchase Price," which is $267,100.

=== LOGS (per-agent) ===
{'TabuSynth': {'cot': 'To determine the fair value of Hologic common stock '
                      'used to acquire Suro, we need to analyze the provided '
                      'financial table. The table lists various components of '
                      'the acquisition cost, and the total estimated purchase '
                      'price is given as $267,100.\n'
                      '\n'
                      'The fair value of the Hologic common stock used to '
                      'acquire Suro is directly provided in the table as the '
                      '"Estimated Purchase Price."\n'
                      '\n'
                      '**Calculation**:\n'
                      'The fair value of Hologic common stock used to acquire '
                      'Suro is the "Estimated Purchase Price," which is '
                      '$267,100.\n'
                      '\n'
                      '**Answer**: $267,100',
               'result': 'To determine the fair value of Hologic common stock '
                         'used to acquire Suro, we need to analyze the '
                         'provided financial table. The table lists various '
                         'components of the acquisition cost, and the total '
                         'estimated purchase price is given as $267,100.\n'
                         '\n'
                         'The fair value of the Hologic common stock used to '
                         'acquire Suro is directly provided in the table as '
                         'the "Estimated Purchase Price."\n'
                         '\n'
                         '**Calculation**:\n'
                         'The fair value of Hologic common stock used to '
                         'acquire Suro is the "Estimated Purchase Price," '
                         'which is $267,100.\n'
                         '\n'
                         '**Answer**: $267,100',
               'raw': 'To determine the fair value of Hologic common stock '
                      'used to acquire Suro, we need to analyze the provided '
                      'financial table. The table lists various components of '
                      'the acquisition cost, and the total estimated purchase '
                      'price is given as $267,100.\n'
                      '\n'
                      'The fair value of the Hologic common stock used to '
                      'acquire Suro is directly provided in the table as the '
                      '"Estimated Purchase Price."\n'
                      '\n'
                      '**Calculation**:\n'
                      'The fair value of Hologic common stock used to acquire '
                      'Suro is the "Estimated Purchase Price," which is '
                      '$267,100.\n'
                      '\n'
                      '**Answer**: $267,100'},
 'Contextron': {'cot': '**Data Extraction**:\n'
                       'From the text context:\n'
                       '- The acquisition of Suro Surgical Systems, Inc. '
                       'involved a total estimated purchase price of '
                       '$267,100.\n'
                       '- The components of the purchase price included:\n'
                       '  - 2,300 shares of Hologic common stock valued at '
                       '$106,500.\n'
                       '  - Cash paid of $139,000.\n'
                       '  - Approximately $2,600 for acquisition-related fees '
                       'and expenses.',
                'result': 'From the table data:\n'
                          '- The fair value of Hologic common stock used to '
                          'acquire Suro is directly provided as the "Estimated '
                          'Purchase Price," which is $267,100.\n'
                          '\n'
                          '**Calculation Steps**:\n'
                          'The fair value of Hologic common stock used to '
                          'acquire Suro is explicitly stated in the table as '
                          'the "Estimated Purchase Price." No further '
                          'calculation is needed as the value is directly '
                          'provided.\n'
                          '\n'
                          '**Answer**: $267,100\n'
                          '\n'
                          '**Additional Context Required**: None. The fair '
                          'value of the Hologic common stock used to acquire '
                          'Suro is clearly stated in the provided data.',
                'raw': '**Data Extraction**:\n'
                       'From the text context:\n'
                       '- The acquisition of Suro Surgical Systems, Inc. '
                       'involved a total estimated purchase price of '
                       '$267,100.\n'
                       '- The components of the purchase price included:\n'
                       '  - 2,300 shares of Hologic common stock valued at '
                       '$106,500.\n'
                       '  - Cash paid of $139,000.\n'
                       '  - Approximately $2,600 for acquisition-related fees '
                       'and expenses.\n'
                       '\n'
                       'From the table data:\n'
                       '- The fair value of Hologic common stock used to '
                       'acquire Suro is directly provided as the "Estimated '
                       'Purchase Price," which is $267,100.\n'
                       '\n'
                       '**Calculation Steps**:\n'
                       'The fair value of Hologic common stock used to acquire '
                       'Suro is explicitly stated in the table as the '
                       '"Estimated Purchase Price." No further calculation is '
                       'needed as the value is directly provided.\n'
                       '\n'
                       '**Answer**: $267,100\n'
                       '\n'
                       '**Additional Context Required**: None. The fair value '
                       'of the Hologic common stock used to acquire Suro is '
                       'clearly stated in the provided data.'},
 'SummaCraft': {'cot': '(omitted)',
                'result': '```json\n'
                          '{\n'
                          '  "Question": "what is the fair value of hologic '
                          'common stock used to acquire suros?",\n'
                          '  "Calculation": "The fair value of Hologic common '
                          'stock used to acquire Suro is directly provided in '
                          "the table as the 'Estimated Purchase Price,' which "
                          'is $267100. No further calculation is needed as the '
                          'value is explicitly stated.",\n'
                          '  "Answer": "$267100",\n'
                          '  "Source": "table"\n'
                          '}\n'
                          '```\n'
                          '\n'
                          'Answer Echoes:\n'
                          '- The fair value of Hologic common stock used to '
                          'acquire Suro is directly provided as the "Estimated '
                          'Purchase Price," which is $267,100.',
                'raw': '```json\n'
                       '{\n'
                       '  "Question": "what is the fair value of hologic '
                       'common stock used to acquire suros?",\n'
                       '  "Calculation": "The fair value of Hologic common '
                       'stock used to acquire Suro is directly provided in the '
                       "table as the 'Estimated Purchase Price,' which is "
                       '$267,100. No further calculation is needed as the '
                       'value is explicitly stated.",\n'
                       '  "Answer": "$267,100",\n'
                       '  "Source": "table"\n'
                       '}\n'
                       '```'}}
